Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 41
2007 102
2008 93
2009 102
2010 128
2011 113
2012 128
2013 145
2014 139
2015 117
2016 90
2017 84
2018 80
2019 37
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

1,169 results
Results by year
Filters applied: . Clear all
Page 1
Preface
Nakanishi T and Kuragano T. Blood Purif 2019. PMID 30943485 Free article.
Alveolar bone healing in rats: micro-CT, immunohistochemical and molecular analysis.
Hassumi JS, et al. J Appl Oral Sci 2018. PMID 29898174 Free PMC article.
OBJECTIVES: The aim of this study was therefore to characterize the alveolar bone healing after upper incisor extraction in rats by micro computed tomographic (Micro-CT), immunohistochemical and real-time polymerase chain reaction (RT-PCR) analysis. ...Subsequently, the histological analyses and immunostaining of osteoprotegerin (OPG), receptor activator of nuclear kappa B ligand (RANKL) and tartrate resistant acid phosphate (TRAP) was performed. ...
OBJECTIVES: The aim of this study was therefore to characterize the alveolar bone healing after upper incisor extraction in rats by micro co …
Circulating osteoprotegerin levels are elevated in rheumatoid arthritis: a systematic review and meta-analysis.
Wang P, et al. Clin Rheumatol 2017 - Review. PMID 28698901
This study aimed to systemically review the evidence regarding the relationship between the circulating blood osteoprotegerin (OPG) level and rheumatoid arthritis (RA), as well as the potential influential factors. ...Pooled standard mean difference (SMD) with 95% confidence interval (CI) was calculated by fixed-effects or random-effect model analysis. ...
This study aimed to systemically review the evidence regarding the relationship between the circulating blood osteoprotegerin (OPG) l …
Circulating Levels of Osteoprotegerin, Osteocalcin and Osteopontin in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
Liu LN, et al. Immunol Invest 2019. PMID 30188218
OBJECTIVE: Currently published data regarding the potential role of osteoprotegerin (OPG), osteocalcin (OCN) and osteopontin (OPN) for the discrimination between rheumatoid arthritis (RA) and osteoarthritis (OA) are contradictory. ...Subgroup analysis indicated that plasma/serum OPG levels had no significant differences between RA patients and OA patients in Europe and Asian. ...
OBJECTIVE: Currently published data regarding the potential role of osteoprotegerin (OPG), osteocalcin (OCN) and osteopontin (OPN) fo …
Current and future circulating biomarkers for cardiac amyloidosis
Luciani M, et al. Acta Pharmacol Sin 2018 - Review. PMID 29770800 Free PMC article.
Early markers (free light chains, serum amyloid A, β(2)-microglobulin, osteopontin and osteoprotegerin) can be employed for disease detection. ...
Early markers (free light chains, serum amyloid A, β(2)-microglobulin, osteopontin and osteoprotegerin) can be employed for disease d …
Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants.
Tschiderer L, et al. PLoS One 2017. PMID 28837646 Free PMC article.
Study-specific risk ratios were combined with random-effects meta-analysis. RESULTS: When comparing individuals in the top with those in the bottom third of osteoprotegerin concentration, the combined risk ratio was 1.83 (95% confidence interval: 1.46, 2.30; P<0.001; I2 = 76.8%) for cardiovascular disease, 1.72 for coronary heart disease (1.26, 2.37; P = 0.001; I2 = 83.5%), and 1.58 for stroke (1.18, 2.12; P = 0.002; I2 = 65.2%). ...Magnitudes of associations did not differ according to the proportion of males, geographical region, or osteoprotegerin assay manufacturer. ...
Study-specific risk ratios were combined with random-effects meta-analysis. RESULTS: When comparing individuals in the top with those …
Osteoprotegerin concentration is associated with the presence and severity of peripheral arterial disease in type 2 diabetes mellitus.
Demková K, et al. Vasa 2018. PMID 29313442 Free article.
BACKGROUND: Osteoprotegerin plays a role in the development of several bone diseases. In addition, osteoprotegerin may contribute to the development of vascular disease. ...In the multivariate linear regression analysis, serum osteoprotegerin (β = -0.005; p = 0.020), higher age, and male gender were significant predictors of TBI. ...
BACKGROUND: Osteoprotegerin plays a role in the development of several bone diseases. In addition, osteoprotegerin may contrib …
Charcot Pathogenesis: A Study of In Vivo Gene Expression
Connors JC, et al. J Foot Ankle Surg 2018. PMID 30368423
The expression levels of receptor activator of nuclear factor kappa-B ligand and osteoprotegerin showed no significant increase in the Charcot neuroarthropathy group compared with the healthy control group. We determined that the levels of receptor activator of nuclear factor kappa-B ligand and osteoprotegerin were not significantly increased in Charcot neuroarthropathy patients compared with healthy control patients. ...
The expression levels of receptor activator of nuclear factor kappa-B ligand and osteoprotegerin showed no significant increase in th …
Elevated serum osteoprotegerin levels in women: friend or foe?
Sasso GR, et al. Rev Assoc Med Bras (1992) 2015 - Review. PMID 26841162 Free article.
INTRODUCTION: osteoprotegerin has emerged as a new candidate for the treatment of osteoporosis. However, high levels of osteoprotegerin have been linked to vascular calcification, an independent and well-defined risk factor for cardiovascular disease (CVD) and mortality. Thus, the action of osteoprotegerin in these situations has been questioned. OBJECTIVE: to evaluate the effect of osteoprotegerin (OPG) on the human body, especially in bone tissue and in vascular diseases. ...
INTRODUCTION: osteoprotegerin has emerged as a new candidate for the treatment of osteoporosis. However, high levels of osteoprote
1,169 results
Jump to page
Feedback